Find out what makes us such a unique institution and discover the vibrant student life that is at the heart of our community.
Today, St George’s, University of London has launched a Coronavirus Action Fund to support research in response to the coronavirus pandemic and continue work to improve health.
See how our research transforms people’s lives in our community, throughout the UK and around the world
Read our guidance for staff, students and applicants.
An international group of researchers believe there is enough evidence that anti-malarial drugs could be repurposed to treat COVID-19 and that they should be assessed for efficacy in clinical trials.
The Research Excellence Framework (REF) is the UK’s system for assessing the quality of research in UK higher education institutions. It takes place every seven years and the next exercise will be conducted in 2021.
REF 2021 is undertaken by the UK higher education funding bodies: Research England, the Scottish Funding Council, the Higher Education Funding Council for Wales, and the Department for the Economy, Northern Ireland.
The funding bodies’ shared policy aim for research assessment is to secure the continuation of a world-class, dynamic and responsive research base across the full academic spectrum within UK higher education. The purpose of the REF is:
to provide accountability for public investment in research and produce evidence of the benefits of this investment
to provide benchmarking information and establish reputational yardsticks, for use within the Higher Education sector and for public information
to inform the selective allocation of funding for research.
REF will assess the quality of outputs (e.g. publications), their impact beyond academia, and the environment that supports research.
REF has published all key documents to guide the REF submission available at www.ref.ac.uk/.
The REF replaces the previous Research Assessment Exercise.
St George’s was assessed in the areas of Clinical Medicine and Public Health, Health Services and Primary Care. St George’s research excellence score for REF 2014:
St George’s ranked 4th in the UK for impact for REF 2014.
St George’s ranked joint 42nd in the UK, which was a rise of 24 places from the Research Assessment Exercise 2008.
at St George’s the percentage of research rated as internationally excellent or world leading rose to 70 per cent (from 44 per cent in RAE 2008).
almost 30 per cent of our research was ranked at the top (internationally leading at 4*), compared to 5.4 per cent in RAE 2008.
Parental smoking was linked with poor respiratory health in children by St George's-led investigations in the 1990s.
Our studies have influenced UK government and World Health Organisation recommendations for salt intake.
In 2009, St George's researchers developed new diagnostic testing procedures for Clostridium difficile (C diff).
Since the 1990s, a group of researchers based at St George's has made a number of seminal contributions in the development of dual targeting antibiotics and the circumvention of antibiotic resistance.
Working with a small start-up company, Professor Angus Dalgleish developed several thalidomide analogues, including lenalinomide and pomalidomide.
Researchers from St George's have evaluated and optimised anti-fungal therapy for cryptococcal meningitis, the commonest cause of adult meningitis in sub-Saharan Africa.
Browser does not support script.